The global Biopharmaceutical Contract Manufacturing Market is expected to be worth around US$ 8.4 billion in 2021, growing at a CAGR of 10.5% to US$ 18.7 billion by 2029.
Biopharmaceutical manufacturing companies offer benefits such as shorter overall time to market for new drugs, access to expensive technologies, and greater flexibility. A number of large corporations have outsourced their biopharmaceutical manufacturing operations as a result of these factors. Biopharmaceutical companies with limited in-house production capacity prefer contract manufacturing of biopharmaceuticals.
Pharmaceutical companies prioritise core competencies and, as a result, prefer not to take financial risks when determining the final dose of medications. This is expected to fuel the global biopharmaceutical contract manufacturing market, which is expected to be worth US$ 18.7 billion by 2029.
Key Market Segments Covered in Biopharmaceutical Contract Manufacturing Industry Research:
By Platform Type:
- Mammalian Based
- Microbial Based
By Product Type:
- Monoclonal Antibodies
- Recombinant Protein
- Vaccine
- Insulin
- Growth factor
- Interferons
- Others
By Application Type:
- Clinical
- Commercial
By Therapeutic Area Type:
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Others
Read More@ https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market
Key Takeaways of Biopharmaceutical Contract Manufacturing Market Study
- Although microbial-based platforms are widely used for pharmaceutical production, mammalian-based cell culture is expected to gain traction due to increased efficiency and rising demand during the forecast period.
- Monoclonal antibodies currently hold a larger share of the biopharmaceutical contract manufacturing market due to their superior efficacy and increasing adoption for the treatment of chronic diseases.
- North America is expected to be the most profitable region in the global biopharmaceutical contract manufacturing market, which will provide opportunities for market participants.
- Commercial applications of biopharmaceutical contract manufacturing are expected to outnumber clinical applications by the end of 2029.
Key Market Players:
- Catalent Inc.
- Lonza Group Ag
- Patheon N.V. (Thermo Fisher Scientific Inc.)
- Abzena Plc.
- Sandoz International GmbH (Novartis AG)
- Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
- Baxter Pharmaceutical Solutions LLC (Baxter Inc.)
- AbbVie Contract Manufacturing (AbbVie Inc.)
- Samsung Biologics Co. Ltd.
- ProBioGen AG
- Pfizer Centre Source Ltd (Pfizer Inc.)
- Novasep
- Biomeva GmbH
- Kbi Biopharma Inc
- Rentschler Biotechnologie GmbH
- Ajinomoto Althea Inc. (Ajinomoto Co., Inc.)
Biopharmaceutical Logistic is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers.
Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency.
According to this study, over the next five years the Biopharmaceutical Logistic market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 89900 million by 2024, from US$ 71000 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Biopharmaceutical Logistic business, shared in Chapter 3.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-biopharmaceutical-logistic-2019-2024-23The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.Deutsche Post DHLKuehne + NagelFedExAmerisourceBergenUPS (Marken)DB SchenkerXPO LogisticsPanalpinaNippon ExpressGEODISVersaColdAgilityDSVSinotransKerry LogisticsSF ExpressCEVACH RobinsonAir Canada CargoThis report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Logistic market by product type, application, key manufacturers and key regions and countries.This study considers the Biopharmaceutical Logistic value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Cold Chain LogisticsNon-cold Chain LogisticsSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.Ground ShippingSea ShippingAir ShippingThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global Biopharmaceutical Logistic consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Biopharmaceutical Logistic market by identifying its various subsegments.Focuses on the key global Biopharmaceutical Logistic manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Biopharmaceutical Logistic with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Biopharmaceutical Logistic submarkets, with respect to key regions (along with their respective key countries).Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-biopharmaceutical-logistic-2019-2024-23Table of content2019–2024 Global Biopharmaceutical Logistic Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global Biopharmaceutical Logistic Consumption 2014–20242.1.2 Biopharmaceutical Logistic Consumption CAGR by Region2.2 Biopharmaceutical Logistic Segment by Type2.2.1 Cold Chain Logistics2.2.2 Non-cold Chain Logistics2.3 Biopharmaceutical Logistic Consumption by Type2.3.1 Global Biopharmaceutical Logistic Consumption Market Share by Type (2014–2019)2.3.2 Global Biopharmaceutical Logistic Revenue and Market Share by Type (2014–2019)2.3.3 Global Biopharmaceutical Logistic Sale Price by Type (2014–2019)2.4 Biopharmaceutical Logistic Segment by Application2.4.1 Ground Shipping2.4.2 Sea Shipping2.4.3 Air Shipping2.5 Biopharmaceutical Logistic Consumption by Application2.5.1 Global Biopharmaceutical Logistic Consumption Market Share by Application (2014–2019)2.5.2 Global Biopharmaceutical Logistic Value and Market Share by Application (2014–2019)2.5.3 Global Biopharmaceutical Logistic Sale Price by Application (2014–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
